(Q39290476)

10 September 2017

title

Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism (English)

1 reference

10 September 2017

0 references

1

1 reference

10 September 2017

13

1 reference

10 September 2017

Luis Brieva

2

1 reference

10 September 2017

Franz Tatzber

3

1 reference

10 September 2017

Mariona Jové

4

1 reference

10 September 2017

Daniel Cacabelos

5

1 reference

10 September 2017

Anna Cassanyé

6

1 reference

10 September 2017

Lucia Lanau-Angulo

7

1 reference

10 September 2017

Jordi Boada

8

1 reference

10 September 2017

José C E Serrano

9

1 reference

10 September 2017

Cristina González

10

1 reference

10 September 2017

Lourdes Hernández

11

1 reference

10 September 2017

Sílvia Peralta

12

1 reference

10 September 2017

Manuel Portero-Otin

14

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 September 2012

1 reference

Journal of Neurochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

123

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

622-634

1 reference

Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Production of superoxide anions by a CNS macrophage, the microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

PPAR-gamma: Therapeutic Potential for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Little change in cerebrospinal fluid amino acids in subtypes of multiple sclerosis compared with acute polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Mitochondria in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Biomarkers of disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Oxidative damage in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Sweet and sour--oxidative and carbonyl stress in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Site-specific modification of positively-charged surfaces on human serum albumin by malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The involvement of mitochondria in the pathogenesis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Activation of NF-kappa B by reactive oxygen intermediates in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Expression of retinoid X receptor β is induced in astrocytes during corpus callosum demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Hydroxynonenal, toxic carbonyls, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Pathological aspects of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The importance of NAD in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Increasing CNS noradrenaline reduces EAE severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

XCMS Online: a web-based platform to process untargeted metabolomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

The role of antibodies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Metabolomics identifies perturbations in human disorders of propionate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Factors predisposing to the development of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Protective effects and mechanisms of sirtuins in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Multicompartmental LC-Q-TOF-Based Metabonomics as an Exploratory Tool to Identify Novel Pathways Affected by Polyphenol-Rich Diets in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2012.07934.X

10.1111/J.1471-4159.2012.07934.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference